Drug Trial Radar · NCT07248956
Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma
Last checked: Nov 19, 2026Latest source record: Dec 23, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
116
Planned (sponsor's estimate)
Start
Dec 22, 2025
Primary completion
Nov 30, 2027
Study completion Dec 30, 2029
Sponsor
- Lead sponsor
- Eye & ENT Hospital of Fudan UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 25, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-center, randomized controlled, prospective clinical study.
Conditions
- Hypopharyngeal Carcinoma
Interventions
FinolizumabDrug
200mg every 3 weeks (q3w) for 2 cycles.
Albumin-Bound Paclitaxel /nab-PaclitaxelDrug
260mg/m², day 1, every 3 weeks (q3w) for 2 cycles.
CisplatinDrug
25mg/m², days 1-3, every 3 weeks (q3w) for 2 cycles.
Definitive radiotherapyRadiation
Definitive radiotherapy (68-70Gy) with concurrent cisplatin-based chemotherapy (25mg/m², days 1-3, every 3 weeks)
Surgery with postoperative radiotherapy or chemoradiotherapy.Procedure
surgery with postoperative radiotherapy or chemoradiotherapy.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Event-free survival (EFS)Time frame: 2 years
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Beijing Tongren Hospital, Capital Medical University
Beijing, China · Not yet recruiting
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, China · Not yet recruiting
Eye & ENT Hospital, Fudan University
Shanghai, China · Recruiting
Zhongshan Hospital of Fudan University
Shanghai, China · Not yet recruiting
Tianjin Medical University Cancer Institute & Hospital
Tianjin, China · Not yet recruiting
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China · Not yet recruiting
Shandong Provincial ENT Hospital
Jinan, Shandong, China · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.